ArticleBiomedicines2022

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study.

Paolo Cameli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.